NRC Health Deferred Revenue Recognized
NRC Health (NRC) reported Deferred Revenue Recognized of $14.93 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2021-11-05
- NRC Health contract with customer, liability, revenue recognized for the quarter ending 2021-03-31 was $7.12M, a 9.88% increase year-over-year.
- NRC Health contract with customer, liability, revenue recognized for the quarter ending 2020-03-31 was $6.47M, a 11.17% decline year-over-year.
- NRC Health contract with customer, liability, revenue recognized for the quarter ending 2019-03-31 was $7.29M, a 11.52% decline year-over-year.
- NRC Health contract with customer, liability, revenue recognized for the quarter ending 2018-06-30 was $7.73M.
- NRC Health contract with customer, liability, revenue recognized for fiscal 2020 was $16.08M, a 1.89% increase from fiscal 2019.
- NRC Health contract with customer, liability, revenue recognized for fiscal 2019 was $15.79M, a 3.59% decline from fiscal 2018.
- NRC Health contract with customer, liability, revenue recognized for fiscal 2018 was $16.37M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 3 month as first filed | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 9 month as first filed | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|---|---|
| 2021-09-30 | $14.93M 10-Q · filed 2021-11-05 | ||||||
| 2021-06-30 | $11.61M 10-Q · filed 2021-08-06 | ||||||
| 2021-03-31 | $7.12M 10-Q · filed 2021-05-07 | ||||||
| 2020-12-31 | $16.08M 10-K · filed 2021-03-05 | ||||||
| 2020-09-30 | $15.37M 10-Q · filed 2021-11-05 | ||||||
| 2020-06-30 | $11.93M 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | $6.47M 10-Q · filed 2021-05-07 | ||||||
| 2019-12-31 | $15.79M 10-K · filed 2021-03-05 | ||||||
| 2019-09-30 | $15.21M 10-Q · filed 2020-11-06 | ||||||
| 2019-06-30 | $12.23M 10-Q · filed 2020-08-07 | ||||||
| 2019-03-31 | $7.29M 10-Q · filed 2020-05-08 | ||||||
| 2018-12-31 | $16.37M 10-K · filed 2020-03-06 | ||||||
| 2018-09-30 | $15.38M 10-Q · filed 2019-11-08 | $15.36M 10-Q · filed 2018-11-08 | |||||
| 2018-06-30 | $7.73M 10-Q · filed 2018-08-09 | $13.63M 10-Q · filed 2019-08-08 | $13.58M 10-Q · filed 2018-08-09 | ||||
| 2018-03-31 | $8.24M 10-Q · filed 2019-05-08 | $8.23M 10-Q · filed 2018-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |